These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12898516)
21. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296 [TBL] [Abstract][Full Text] [Related]
22. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Altucci L; Rossin A; Raffelsberger W; Reitmair A; Chomienne C; Gronemeyer H Nat Med; 2001 Jun; 7(6):680-6. PubMed ID: 11385504 [TBL] [Abstract][Full Text] [Related]
23. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Aggarwal BB; Bhardwaj U; Takada Y Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190 [TBL] [Abstract][Full Text] [Related]
24. N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines. Cuello M; Coats AO; Darko I; Ettenberg SA; Gardner GJ; Nau MM; Liu JR; Birrer MJ; Lipkowitz S Cell Death Differ; 2004 May; 11(5):527-41. PubMed ID: 14765134 [TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor and trail interactions in epithelial-derived cells. Gibson SB Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179 [TBL] [Abstract][Full Text] [Related]
26. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
27. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
28. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Kim M; Park SY; Pai HS; Kim TH; Billiar TR; Seol DW Cancer Res; 2004 Jun; 64(12):4078-81. PubMed ID: 15205314 [TBL] [Abstract][Full Text] [Related]
29. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766 [TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis. Ou D; Wang X; Metzger DL; James RF; Pozzilli P; Plesner A; Korneluk RG; Verchere CB; Tingle AJ Hum Immunol; 2005 Mar; 66(3):274-84. PubMed ID: 15784465 [TBL] [Abstract][Full Text] [Related]
31. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. Gao X; Deeb D; Jiang H; Liu YB; Dulchavsky SA; Gautam SC J Exp Ther Oncol; 2005; 5(1):39-48. PubMed ID: 16416600 [TBL] [Abstract][Full Text] [Related]
32. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. Myklebust JH; Josefsen D; Blomhoff HK; Levy FO; Naderi S; Reed JC; Smeland EB J Cell Physiol; 1999 Jul; 180(1):71-80. PubMed ID: 10362019 [TBL] [Abstract][Full Text] [Related]
33. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. Han J; Goldstein LA; Gastman BR; Rabinowich H J Biol Chem; 2006 Apr; 281(15):10153-63. PubMed ID: 16478725 [TBL] [Abstract][Full Text] [Related]
34. Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells. Yang C; Kaushal V; Shah SV; Kaushal GP Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1710-7. PubMed ID: 17311906 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637 [TBL] [Abstract][Full Text] [Related]
36. Differences in TRAIL-induced changes of Mcl-1 expression among distinct human colon epithelial cell lines. Vaculová A; Hofmanová J; Zatloukalová J; Kozubík A Exp Cell Res; 2009 Nov; 315(19):3259-66. PubMed ID: 19782681 [TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway. Leu CM; Chang C; Hu C Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823 [TBL] [Abstract][Full Text] [Related]
38. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. Clohessy JG; Zhuang J; de Boer J; Gil-Gómez G; Brady HJ J Biol Chem; 2006 Mar; 281(9):5750-9. PubMed ID: 16380381 [TBL] [Abstract][Full Text] [Related]
39. Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression. Henson ES; Hu X; Gibson SB Clin Cancer Res; 2006 Feb; 12(3 Pt 1):845-53. PubMed ID: 16467098 [TBL] [Abstract][Full Text] [Related]
40. A new quantitative assay for cytochrome c release in apoptotic cells. Waterhouse NJ; Trapani JA Cell Death Differ; 2003 Jul; 10(7):853-5. PubMed ID: 12815469 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]